Drug Type Fusion protein |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | - | 15 Sep 2024 | |
Classical Hodgkin's Lymphoma | Phase 1 | - | 15 Sep 2024 | |
Refractory Hodgkin Lymphoma | Phase 1 | - | 15 Sep 2024 | |
Neoplasms | Preclinical | TW | 06 Feb 2024 |